Disease Attributes  >>  dilmapimod (SB-681323)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dilmapimod (SB-681323) / GSK
NCT00144859 / 2004-002769-18: Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)

Completed
2
82
Europe
SB681323
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive, Chronic Obstructive Pulmonary Disease (COPD)
 
 

Download Options